Gladstone NOW: The Campaign Join Us on the Journey ✕
106 - 117 of 117 Results Clear All
SAN FRANCISCO, CA—A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Ding Lab Cardiovascular Disease Diabetes Stem Cells/iPSCs
New study establishes platform for investigating chromosome regulation during early human development.
Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—There is no easy way to study diseases of the brain. Extracting brain cells, or neurons, from a living patient is difficult and risky, while examining a patient’s brain post-mortem usually only reveals the disease’s final stages.
Huang Lab Alzheimer’s Disease Stem Cells/iPSCs
SAN FRANCISCO, CA—In the aftermath of a heart attack, cells within the region most affected shut down. They stop beating. And they become entombed in scar tissue.
Srivastava Lab Stem Cells/iPSCs Stem Cells/iPSCs
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his “Commitment to a Cure” from The ALS Association Golden West Chapter. This annual award represents the exceptional determination, spirit and dedication to the fight against amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
ALS Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—Gladstone Institutes’ Senior Investigator Shinya Yamanaka, MD, PhD, is one of 11 medical researchers to win a new, high-profile $3 million award from a group of high-tech sponsors, including the founders of Facebook and Google.
Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that, like embryonic stem cells, are capable of developing into any cell in the human body.
Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—July 5, 2012—Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell—called an iPS cell—that is derived from adult skin cells.
Stem Cells/iPSCs
SAN FRANCISCO, CA—May 25, 2012—The California Institute for Regenerative Medicine (CIRM) has awarded Deepak Srivastava, MD—who directs cardiovascular and stem cell research at the Gladstone Institutes—a $6.3 million Early Translational Award to promote stem cell-based innovation. Dr.
Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes today are announcing a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks—by converting scar-forming cardiac cells into beating heart muscle.
Srivastava Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.
Ding Lab Stem Cells/iPSCs Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have found a new way to make beating heart cells from the body's own cells that could help regenerate damaged hearts.
Srivastava Lab Stem Cells/iPSCs
